BMC | Obstetrics and Gynecology Residency Program

General Information
Curriculum
Core Competency
Schedules
Evaluation
Research
Protocols
Links

Main

BUMC

GYN PGY3/PGY4
Carcinomas of the Genital Tract

1. Describe the epidemiology and pathogenesis of invasive endometrial cancer.
2. Describe the typical clinical manifestations of invasive endometrial cancer.
3. Describe the FIGO staging of invasive endometrial cancer.
4. Describe the differential diagnosis of invasive endometrial cancer.
5. Describe the treatment of invasive endometrial cancer.
6. Describe the prognosis for invasive endometrial cancer.
7. With the assistance of a subspecialist, provide definitive treatment for a patient with endometrial carcinoma.
8. Manage, in combination with a subspecialist, the common complications of surgical and radiation treatment for endometrial cancer.

Invasive cervical cancer

1. Describe the epidemiology and pathogenesis of invasive cervical cancer.
2. Describe the typical clinical manifestations of invasive cervical cancer.
3. Describe the FIGO staging of invasive cervical cancer.
4. Describe the differential diagnosis of invasive cervical cancer.
5. Describe the treatments for invasive cervical cancer.
6. Describe the prognosis for invasive cervical cancer.
7. With the assistance of a subspecialist, provide definitive treatment for a patient with invasive cervical cancer.
8. Manage, in combination with a subspecialist, the common complications of surgical and radiation treatment for cervical cancer.
9. Describe the psychosocial concerns of patients who have invasive cervical cancer.
10. Describe the indications for referral to a specialist for treatment of psychosocial dysfunction.

Carcinoma of the fallopian tube

1. Describe the epidemiology and pathogenesis of fallopian tube cancer.
2. Describe the typical clinical manifestations of fallopian tube cancer.
3. Describe the histology, FIGO staging, and prognosis of fallopian tube tumors.
4. Perform appropriate tests to diagnose cancer of the fallopian tube.
5. Describe the treatment for fallopian tube cancer based on:

a. Type
b. Grade
c. Stage
d. Patient characteristics

1. Describe the epidemiology and pathogenesis of ovarian cancer.
2. Describe the inherited syndromes that increase a woman’s likelihood of developing ovarian cancer.
3. Describe the screening protocols that may identify patients who have an inherited form of ovarian cancer.
4. Describe the typical clinical manifestations of ovarian cancer.
5. Describe the histology, staging, and prognosis for:

a. Epithelial tumors
b. Germ cell tumors
c. Stromal tumors
d. Sarcomas
e. Metastatic tumors
f. Tumors of low malignant potential

a. Ultrasonography
b. Serum tumor markers
c. Cytology from paracentesis
d. CT scan

a. Type
b. Grade
c. Stage
d. Patient characteristics

1. Describe the epidemiology and pathogenesis of invasive vaginal cancer.
2. Describe the typical clinical manifestations of invasive vaginal cancer.
3. Describe the FIGO staging of invasive vaginal cancer.
4. Describe the differential diagnosis of invasive vaginal cancer.
5. Describe the treatments for invasive vaginal cancer.
6. Describe the prognosis for invasive vaginal cancer.
7. With the assistance of a subspecialist, provide treatment for a patient with invasive cancer of the vagina.
8. Manage, in combination with a subspecialist, the common complications of surgical and radiation treatment for vaginal cancer.

1. Describe the epidemiology and pathogenesis of invasive vulvar lesions:

a. Melanoma
b. Squamous cell cancer
c. Basal cell carcinoma
d. Paget’s disease
e. Sarcoma
f. Verrucous carcinoma
g. Bartholin’s gland carcinoma

2. Describe the clinical manifestations of invasive vulvar malignancies.
3. Describe the staging of invasive vulvar cancers using the system adopted by the International Federation of Gynecology and Obstetrics (FIGO).
4. Describe the differential diagnosis of vulvar cancer.
5. Describe the treatments for invasive vulvar malignancies.
6. Describe the prognosis for invasive vulvar malignancies.
7. With the assistance of a subspecialist, provide definitive treatment for a patient with an invasive vulvar malignancy.
8. Manage, in consultation with a subspecialist, the common complications of surgical and radiation treatment for invasive vulvar cancer.
9. Describe the impact of treatment of vulvar cancer on sexual function and appropriately refer the patient for specialized treatment if sexual dysfunction develops.

Hydatidiform Mole
1. Describe the epidemiology and pathogenesis
2. Describe the typical clinical manifestations
3. Diagnose GTD ant its complications
4. Distinguish between a complete and partial hydatidiform mole
5. Describe appropriate follow up for a patient who has had suction evacuation of a molar pregnancy
6. Describe indications and complications of chemotherapy for GTD
7. Describe the indications for referral to a subspecialist
8. Counsel the patient regarding recurrence risks.

1. Describe the conditions that may precede malignant GTD.
2. Describe the histologic appearance of invasive mole versus choriocarcinoma versus placental site trophoblastic tumor.
3. Diagnose malignant GTD using a combination of physical examination, ?-hCG, chest X-ray, CT scan, and ultrasonography.
4. Classify GTD into good prognosis (low risk) versus poor prognosis (high risk).
5. Describe the medical and surgical management of malignant GTD.
6. Provide, in consultation with a subspecialist, medical and surgical treatment for a patient with malignant GTD.
7. Provide appropriate follow-up at the completion of treatment.
8. Counsel patients regarding risk of recurrence and prognosis for future pregnancies.

About BMC | Employment | Disclaimer | BUSM